Clinical Trials Browser

Terminated × Kidney Neoplasms × Bortezomib × Clear all

NCT01100242 2015-09-17

Velcade and Sorafenib in Unresected or Metastatic Renal Cell Carcinoma

Phase 2 Terminated

17 enrolled 6 charts

Carcinoma, Renal Cell, Kidney Neoplasms